Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3T5L9 | — |
Administration of expired vaccine.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-year-old male patient who received HBV (Engerix B) (batch number 3T5L9, expiry date 09-MAR-2025) for prophylaxis. On 03-APR-2025, the patient received Engerix B. On 03-APR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Administration of expired vaccine.). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-APR-2025 The nurse practitioner mentioned that a patient received an expired dose of Engerix-B on 3rd April 2025 which led to expired vaccine used. The nurse asked if the patients should be re vaccinated.; Sender's Comments: US-GSK-US2025040983:same reporter/ Different patient US-GSK-US2025040987:same reporter/ Different patient US-GSK-US2025040989:same reporter/ Different patient US-GSK-US2025040991:same reporter/ Different patient